Clinical Trial for the Evaluation of the Efficacy and Safety of PVGL on Mild Osteoarthritis
Not Applicable
Completed
- Conditions
- Diseases of the musculoskeletal system and connective tissue
- Registration Number
- KCT0007603
- Lead Sponsor
- INE B
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 146
Inclusion Criteria
Subjects with VAS 30mm or greater
Subjects whose Kellgren-Lawrence grade on a knee X-ray corresponds to I or II
Subjects who have agreed to participate in this study and provided informed consent
Exclusion Criteria
Subjects currently being treated for major cardiovascular, immunologic, respiratory, hepatic, genitourinary, nervous, musculoskeletal system, infectious disease, and malignant tumor
Subjects with specific arthritis other than degenerative factors
Subjects with less than 2mm of joint space width
Subjects who have used arthritis-related medicines or health supplements for joint health within one month
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total K-WOMAC points and scores for each subject
- Secondary Outcome Measures
Name Time Method VAS, SF-36